 |
Portail HAL - Université de Lille |  |
Article dans une revue
An update on the management of sporadic desmoid-type fibromatosis: a european consensus initiative between sarcoma patients euronet (spaen) and european organization for research and treatment of cancer (eortc)/soft tissue and bone sarcoma group (stbsg)
Abstract : Desmoid-type fibromatosis is a rare and locally aggressive monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Currently, there is no established or evidence-based treatment approach available for this disease. Therefore, in 2015 the European Desmoid Working Group published a position paper giving recommendations on the treatment of this intriguing disease. Here, we present an update of this consensus approach based on professionals' AND patients' expertise following a round table meeting bringing together sarcoma experts from the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group with patients and patient advocates from Sarcoma PAtients EuroNet. In this paper, we focus on new findings regarding the prognostic value of mutational analysis in desmoid-type fibromatosis patients and new systemic treatment options.
Littérature citée [81 références]
https://hal.univ-lille.fr/hal-02639170
Contributeur : Lilloa Université de Lille <>
Soumis le : jeudi 28 mai 2020 - 11:28:14
Dernière modification le : mercredi 10 juin 2020 - 19:22:08
Contributeur : Lilloa Université de Lille <>
Soumis le : jeudi 28 mai 2020 - 11:28:14
Dernière modification le : mercredi 10 juin 2020 - 19:22:08
Fichier
PIIS092375341934935X.pdf
Publication financée par une institution
Licence
Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License
